Tg Therapeutics, Inc. · NASDAQ:TGTX
The Vanguard Group reported a 10.01% stake in Tg Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 8, 2025
The Vanguard Group reported a 10.01% stake in Tg Therapeutics, Inc., 15,596,480 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G/A).
- Stake
- 10.01%
- Shares
- 15,596,480
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.01% | 15,596,480 |
Source
Related
- Tg Therapeutics, Inc.
- The Vanguard Group
- Tg Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Charney Laurence N · Sep 14, 2026
- Form 4 · Charney Laurence N · Aug 7, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 29, 2026
- Schedule 13G · State Street Corp · Nov 10, 2025
- Schedule 13G · State Street Corp · May 13, 2025